Antibody-drug conjugate characterization by chromatographic and electrophoretic techniques

被引:55
|
作者
Chen, Tao [1 ]
Chen, Yan [2 ]
Stella, Cinzia [2 ]
Medley, Colin D. [1 ]
Gruenhagen, Jason A. [1 ]
Zhang, Kelly [1 ]
机构
[1] Genentech Inc, Small Mol Pharmaceut Sci, 1 DNA Way, San Francisco, CA 94080 USA
[2] Genentech Inc, Prot Analyt Chem, 1 DNA Way, San Francisco, CA 94080 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2016年 / 1032卷
关键词
Antibody drug conjugate (ADC); Critical quality attribute (CQA); Drug-to-antibody ratio (DAR); Drug distribution; Peptide mapping; Charge variants; Aggregations; Free drug analysis; PERFORMANCE LIQUID-CHROMATOGRAPHY; MOLECULAR-SIEVE CHROMATOGRAPHY; SIZE-EXCLUSION CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ACUTE MYELOID-LEUKEMIA; MONOCLONAL-ANTIBODY; STRUCTURAL-CHARACTERIZATION; CAPILLARY-ELECTROPHORESIS; PHYSICOCHEMICAL STABILITY; CALICHEAMICIN CONJUGATE;
D O I
10.1016/j.jchromb.2016.07.023
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Due to the inherent structure complexity and component heterogeneity of antibody drug conjugates (ADCs), separation technologies play a critical role in their characterization. In this review, we focus on chromatographic and electrophoretic approaches used to characterize ADCs with respect to drug to-antibody ratio, drug distribution and conjugation sites, free small molecule drugs, charge variants, aggregates and fragments, etc. Chromatographic techniques including reversed-phase, ion exchange, size exclusion, hydrophobic interaction, two-dimensional liquid chromatography, and gas chromatography as well as capillary electrophoretic techniques including capillary electrophoresis sodium dodecyl sulfate, capillary zone electrophoresis and capillary isoelectric focusing are reviewed for their applications in the characterization of ADCs. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 50
页数:12
相关论文
共 50 条
  • [31] Drug-Antibody Ratio of an Antibody-Drug Conjugate by SEC-MALS
    不详
    LC GC NORTH AMERICA, 2018, 36 (06) : 420 - 420
  • [32] Antibody-drug conjugate and novel therapy in lung cancer
    Cho, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1310 - S1311
  • [33] Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate
    Sheyi, Rotimi
    de la Torre, Beatriz G.
    Albericio, Fernando
    PHARMACEUTICS, 2022, 14 (02)
  • [34] Development of an antibody-drug conjugate with broad anticancer activity
    Lin, Siang-Yo
    Szekely, Zoltan
    Lin, Chen-Yong
    Bertino, Joseph R.
    Rather, Gulam Mohmad
    CANCER RESEARCH, 2017, 77
  • [35] Macrocyclic pyrrolobenzodiazepine dimers as antibody-drug conjugate payloads
    Donnell, Andrew F.
    Zhang, Yong
    Stang, Erik M.
    Wei, Donna D.
    Tebben, Andrew J.
    Perez, Heidi L.
    Schroeder, Gretchen M.
    Pan, Chin
    Rao, Chetana
    Borzilleri, Robert M.
    Vite, Gregory D.
    Gangwar, Sanjeev
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (23) : 5267 - 5271
  • [36] Lung cancer treatment with antibody-drug conjugate (ADC)
    Hotta, Katsuyuki
    CANCER SCIENCE, 2018, 109 : 818 - 818
  • [37] Antibody-Drug Conjugate (ADC) Research in Ophthalmology—a Review
    Jie Shen
    Mayssa Attar
    Pharmaceutical Research, 2015, 32 : 3572 - 3576
  • [38] Antibody-Drug Conjugate Payloads; Study of Auristatin Derivatives
    Akaiwa, Michinori
    Dugal-Tessier, Julien
    Mendelsohn, Brian A.
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (03) : 201 - 211
  • [39] Extracellular vesicles as modifiers of antibody-drug conjugate efficacy
    Barok, Mark
    Puhka, Maija
    Yazdi, Narjes
    Joensuu, Heikki
    JOURNAL OF EXTRACELLULAR VESICLES, 2021, 10 (04)
  • [40] Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma
    Al Sbihi, Ali
    Alasfour, Maryam
    Pongas, Georgios
    CANCERS, 2024, 16 (04)